SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
171 hedge funds and large institutions have $825M invested in SANGAMO THERAPEUTICS INC in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 22 closing their positions.
2,317% more call options, than puts
Call options by funds: $200M | Put options by funds: $8.28M
59% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 22
21% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 48
11% more capital invested
Capital invested by funds: $742M → $825M (+$83M)
8% more funds holding
Funds holding: 158 → 171 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$14.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.36M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$6.95M |
| 4 |
Millennium Management
New York
|
+$6.93M |
| 5 |
AC
Apex Capital
Orinda,
California
|
+$6.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.5M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.3M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.61M |
| 4 |
AIC
AWM Investment Company
New York
|
-$4.45M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.46M |
SGMO Hedge Fund Activity: Q1 2015 in Review
171 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2015, worth a combined $825M — up 11% from $742M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new SGMO positions and 22 closed out — a net gain of 13 holders — while 58 added to existing stakes and 48 trimmed.
The largest buyer was Invesco, adding an estimated $14.2M. The largest seller was Adage Capital Partners, cutting an estimated $15.5M.
- 171 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2015, up from 158 in Q4 2014.
- Funds reported $825M of SANGAMO THERAPEUTICS INC stock for Q1 2015, up 11% quarter-over-quarter.
- 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2015 and 22 closed out, a net change of +13 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q1 2015 was Invesco, an estimated $14.2M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q1 2015 was Adage Capital Partners, an estimated $15.5M sold.
Based on aggregated 13F filings for Q1 2015.